These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8165717)

  • 21. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
    Keast DH; Fraser C
    Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
    Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
    Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.
    Van der Niepen P; Sennesael J; Verbeelen D
    Clin Nephrol; 1993 Feb; 39(2):113. PubMed ID: 8448915
    [No Abstract]   [Full Text] [Related]  

  • 24. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phase II clinical study of recombinant human erythropoietin on the anemia of myelodysplastic syndrome].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):928-36. PubMed ID: 8411647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for the use of recombinant human erythropoietin.
    Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
    Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
    [No Abstract]   [Full Text] [Related]  

  • 27. Erythropoietin is approved for the treatment of anemia associated with renal failure, chemotherapy, preoperative anemia, and human immunodeficiency virus disease.
    Savur S; Bonacini M; Bzowej N; Gish R; Wakil A; Osorio R
    Liver Transpl; 2005 Mar; 11(3):366. PubMed ID: 15719399
    [No Abstract]   [Full Text] [Related]  

  • 28. The end stage renal disease program.
    Goodkin DA
    N Engl J Med; 1993 Jul; 329(2):140; author reply 140-1. PubMed ID: 8510703
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythropoietin after bone marrow transplantation.
    Miller CB; Mills S
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):975-92. PubMed ID: 7852219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in anaemia following renal transplantation but not after erythropoietin therapy in a patient with sickle-cell disease.
    Thuraisingham RC; Roger SD; Macdougall IC; Cavill I; Stephens AD; Baker LR; Raine AE
    Nephrol Dial Transplant; 1993; 8(4):371-2. PubMed ID: 8390015
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of anemia in premature infants using recombinant human erythropoietin].
    de Haas V; Raaijmaakers BC; Semmekrot BA; Kollée LA
    Ned Tijdschr Geneeskd; 1995 Apr; 139(15):773-6. PubMed ID: 7723878
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
    Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
    Taniguchi S; Yamasaki K; Shibuya T; Asayama R; Harada M; Niho Y
    Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost of treating predialysis patients with recombinant human erythropoietin.
    Durand-Zaleski I; Goldfarb B; Blum-Boisgard C; Drüeke T; Kreis H
    Nephrol Dial Transplant; 1993; 8(4):311-4. PubMed ID: 8390004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient.
    Kuriyama R; Kogure H; Itoh S; Kikuchi K; Ichikawa N; Nomura Y; Degawa H; Meigata K; Watanabe K; Beck Y; Tomikawa S; Nagao T; Uchida H
    Transplant Proc; 1996 Jun; 28(3):1635. PubMed ID: 8658817
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythropoietin in stem cell transplantation.
    Miller CB; Lazarus HM
    Bone Marrow Transplant; 2001 May; 27(10):1011-6. PubMed ID: 11438814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
    Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
    Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.